Intraoperative dexmedetomidine use can significantly decrease the incidence of severe sleep disturbance on the day of surgery for patients undergoing non-cardiac major surgery, and the effects were most significant in patients receiving gynecological and urological surgery. Furthermore, low-dose dexmedetomidine (0.2-0.4 μg·kg-1·h-1) is most effective for prevention of postoperative sleep disturbance.
Keyphrases
- patients undergoing
- minimally invasive
- coronary artery bypass
- low dose
- surgical site infection
- physical activity
- cardiac surgery
- sleep quality
- end stage renal disease
- left ventricular
- newly diagnosed
- chronic kidney disease
- ejection fraction
- prognostic factors
- percutaneous coronary intervention
- acute kidney injury
- atrial fibrillation